|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zacharakis M, Xynos ID, Lazaris A, Smaro
T, Kosmas C, Dokou A, Felekouras E, Antoniou E, Polyzos A,
Sarantonis J, et al: Predictors of survival in stage IV metastatic
colorectal cancer. Anticancer Res. 30:653–660. 2010.PubMed/NCBI
|
|
3
|
Field K and Lipton L: Metastatic
colorectal cancer-past, progress and future. World J Gastroenterol.
13:3806–3815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shi Y, Lee JS and Galvin KM: Everything
you have ever wanted to know about Yin Yang 1. Biochim Biophys
Acta. 1332:F49–F66. 1997.PubMed/NCBI
|
|
5
|
Khachigian LM: The Yin and Yang of YY1 in
tumor growth and suppression. Int J Cancer. 143:460–465. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Q, Wan M, Shi J, Horita DA, Miller
LD, Kute TE, Kridel SJ, Kulik G and Sui G: Yin Yang 1 promotes
mTORC2-mediated AKT phosphorylation. J Mol Cell Biol. 8:232–243.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu D, Zhang J, Wu Y, Shi G, Yuan H, Lu Z,
Zhu Q, Wu P, Lu C, Guo F, et al: YY1 suppresses proliferation and
migration of pancreatic ductal adenocarcinoma by regulating the
CDKN3/MdM2/P53/P21 signaling pathway. Int J Cancer. 142:1392–1404.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu S, Wang H, Li Y, Xie Y, Huang C, Zhao
H, Miyagishi M and Kasim V: Transcription factor YY1 promotes cell
proliferation by directly activating the pentose phosphate pathway.
Cancer Res. 78:4549–4562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee MH, Lahusen T, Wang RH, Xiao C, Xu X,
Hwang YS, He WW, Shi Y and Deng CX: Yin Yang 1 positively regulates
BRCA1 and inhibits mammary cancer formation. Oncogene. 31:116–127.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JJ, Zhu Y, Yang C, Liu X, Peng YP,
Jiang KR, Miao Y and Xu ZK: Yin Yang-1 increases apoptosis through
bax activation in pancreatic cancer cells. Oncotarget.
7:28498–28509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang JJ, Zhu Y, Xie KL, Peng YP, Tao JQ,
Tang J, Li Z, Xu ZK, Dai CC, Qian ZY, et al: Yin Yang-1 suppresses
invasion and metastasis of pancreatic ductal adenocarcinoma by
downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
Mol Cancer. 13:1302014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang CC, Tsai MF, Hong TM, Chang GC, Chen
CY, Yang WM, Chen JJ and Yang PC: The transcriptional factor YY1
upregulates the novel invasion suppressor HLJ1 expression and
inhibits cancer cell invasion. Oncogene. 24:4081–4093. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Q, Zhang JJ, Ge WL, Chen L, Yuan H,
Meng LD, Huang XM, Shen P, Miao Y and Jiang KR: YY1 inhibits the
migration and invasion of pancreatic ductal adenocarcinoma by
downregulating the FER/STAT3/MMP2 signaling pathway. Cancer Lett.
463:37–49. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Antonio-Andrés G, Rangel-Santiago J,
Tirado-Rodríguez B, Martinez-Ruiz GU, Klunder-Klunder M, Vega MI,
Lopez-Martinez B, Jiménez-Hernández E, Torres Nava J, Medina-Sanson
A and Huerta-Yepez S: Role of Yin Yang-1 (YY1) in the transcription
regulation of the multi-drug resistance (MDR1) gene. Leuk Lymphoma.
59:2628–2638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wottrich S, Kaufhold S, Chrysos E, Zoras
O, Baritaki S and Bonavida B: Inverse correlation between the
metastasis suppressor RKIP and the metastasis inducer YY1:
Contrasting roles in the regulation of chemo/immuno-resistance in
cancer. Drug Resist Updat. 30:28–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vega MI, Valencia-Hipolito A,
Hernandez-Atenogenes M, Vega GG, Mayani H, Mendez-Tenorio A,
Martinez-Maza O, Huerta-Yepez S and Bonavida B: High expression of
Kruppel-Like Factor 4 (KLF4) and its regulation by Yin Yang 1 (YY1)
in non-Hodgkin's B-cell lymphomas: Clinical implication. Cancer
Res. 73 (Suppl 8):S54502013.
|
|
17
|
Cho AA and Bonavida B: Targeting the
overexpressed YY1 in cancer inhibits EMT and metastasis. Crit Rev
Oncog. 22:49–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Palmer MB, Majumder P, Cooper JC, Yoon H,
Wade PA and Boss JM: Yin yang 1 regulates the expression of snail
through a distal enhancer. Mol Cancer Res. 7:221–229. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsumura N, Huang Z, Baba T, Lee PS,
Barnett JC, Mori S, Chang JT, Kuo WL, Gusberg AH, Whitaker RS, et
al: Yin yang 1 modulates taxane response in epithelial ovarian
cancer. Mol Cancer Res. 7:210–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Naidoo K, Clay V, Hoyland JA, Swindell R,
Linton K, Illidge T, Radford JA and Byers RJ: YY1 expression
predicts favourable outcome in follicular lymphoma. J Clin Pathol.
64:125–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Nigris F, Botti C, de Chiara A,
Rossiello R, Apice G, Fazioli F, Fiorito C, Sica V and Napoli C:
Expression of transcription factor Yin Yang 1 in human
osteosarcomas. Eur J Cancer. 42:2420–2424. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang W, Yue Z, Tian Z, Xie Y, Zhang J, She
Y, Yang B, Ye Y and Yang Y: Expression of Yin Yang 1 in cervical
cancer and its correlation with E-cadherin expression and HPV16 E6.
PLoS One. 13:e01933402018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu W, Banerji S, Davie JR, Kassie F, Yee D
and Kratzke R: Yin Yang gene expression ratio signature for lung
cancer prognosis. PLoS One. 8:e687422013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seligson D, Horvath S, Huerta-Yepez S,
Hanna S, Garban H, Roberts A, Shi T, Liu X, Chia D, Goodglick L and
Bonavida B: Expression of transcription factor Yin Yang 1 in
prostate cancer. Int J Oncol. 27:131–141. 2005.PubMed/NCBI
|
|
25
|
Kang W, Tong JH, Chan AW, Zhao J, Dong Y,
Wang S, Yang W, Sin FM, Ng SS, Yu J, et al: Yin Yang 1 contributes
to gastric carcinogenesis and its nuclear expression correlates
with shorter survival in patients with early stage gastric
adenocarcinoma. J Transl Med. 12:802014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanchez-Carbayo M, Socci ND, Lozano J,
Saint F and Cordon-Cardo C: Defining molecular profiles of poor
outcome in patients with invasive bladder cancer using
oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Berrier AL and Yamada KM: Cell-matrix
adhesion. J Cell Physiol. 213:565–573. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Caswell PT and Norman JC: Integrin
trafficking and the control of cell migration. Traffic. 7:14–21.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Missan DS and DiPersio M: Integrin control
of tumor invasion. Crit Rev Eukaryot Gene Expr. 22:309–324. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chinnappan D, Xiao D, Ratnasari A, Andry
C, King TC and Weber HC: Transcription factor YY1 expression in
human gastrointestinal cancer cells. Int J Oncol. 34:1417–1423.
2009.PubMed/NCBI
|
|
33
|
Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok
MT, Wang H, Chen J, Ng SS, Chen M, et al: microRNA-7 is a novel
inhibitor of YY1 contributing to colorectal tumorigenesis.
Oncogene. 32:5078–5088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu J, Zhan Y, Wang J, Wang J, Guo J and
Kong D: Long noncoding RNA LINC01578 drives colon cancer metastasis
through a positive feedback loop with the NF-κB/YY1 axis. Mol
Oncol. 14:3211–3233. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yokoyama NN, Pate KT, Sprowl S and
Waterman ML: A role for YY1 in repression of dominant negative
LEF-1 expression in colon cancer. Nucleic Acids Res. 38:6375–6388.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Z, Han S, Huang W, Wu J, Liu Y, Cai
S, He Y, Wu S and Song W: MicroRNA-215 suppresses cell
proliferation, migration and invasion of colon cancer by repressing
Yin-Yang 1. Biochem Biophys Res Commun. 479:482–488. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tauriello DV, Calon A, Lonardo E and
Batlle E: Determinants of metastatic competency in colorectal
cancer. Mol Oncol. 11:97–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dmello RS, To SQ and Chand AL: Therapeutic
targeting of the tumour microenvironment in metastatic colorectal
cancer. Int J Mol Sci. 22:20672021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen Q, Yang C, Chen L, Zhang JJ, Ge WL,
Yuan H, Meng LD, Huang XM, Shen P, Miao Y and Jiang KR: YY1 targets
tubulin polymerisation-promoting protein to inhibit migration,
invasion and angiogenesis in pancreatic cancer via p38/MAPK and
PI3K/AKT pathways. Br J Cancer. 121:912–921. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zheng L, Chen Y, Ye L, Jiao W, Song H, Mei
H, Li D, Yang F, Li H, Huang K and Tong Q: miRNA-584-3p inhibits
gastric cancer progression by repressing Yin Yang 1-facilitated
MMP-14 expression. Sci Rep. 7:89672017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hamidi H and Ivaska J: Every step of the
way: Integrins in cancer progression and metastasis. Nat Rev
Cancer. 18:533–548. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Seguin L, Desgrosellier JS, Weis SM and
Cheresh DA: Integrins and cancer: Regulators of cancer stemness,
metastasis, and drug resistance. Trends Cell Biol. 25:234–240.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lepsenyi M, Algethami N, Al-Haidari AA,
Algaber A, Syk I, Rahman M and Thorlacius H: CXCL2-CXCR2 axis
mediates αV integrin-dependent peritoneal metastasis of colon
cancer cells. Clin Exp Metastasis. 38:401–410. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Brakebusch C and Fässler R: Beta 1
integrin function in vivo: Adhesion, migration and more. Cancer
Metastasis Rev. 24:403–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Attieh Y, Clark AG, Grass C, Richon S,
Pocard M, Mariani P, Elkhatib N, Betz T, Gurchenkov B and Vignjevic
DM: Cancer-associated fibroblasts lead tumor invasion through
integrin-β3-dependent fibronectin assembly. J Cell Biol.
216:3509–3520. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kato H, Liao Z, Mitsios JV, Wang H-Y,
Deryugina EI, Varner JA, Quigley JP and Shattil SJ: The primacy of
β1 integrin activation in the metastatic cascade. PLoS One.
7:e465762012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mook OR, van Marle J, Jonges R,
Vreeling-Sindelárová H, Frederiks WM and Van Noorden CJ:
Interactions between colon cancer cells and hepatocytes in rats in
relation to metastasis. J Cell Mol Med. 12:2052–2061. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Waisberg J, De Souza Viana L, Affonso
Junior RJ, Silva SR, Denadai MV, Margeotto FB, De Souza CS and
Matos D: Overexpression of the ITGAV gene is associated with
progression and spread of colorectal cancer. Anticancer Res.
34:5599–5607. 2014.PubMed/NCBI
|
|
50
|
Liu QZ, Gao XH, Chang WJ, Gong HF, Fu CG,
Zhang W and Cao GW: Expression of ITGB1 predicts prognosis in
colorectal cancer: A large prospective study based on tissue
microarray. Int J Clin Exp Pathol. 8:12802–12810. 2015.PubMed/NCBI
|
|
51
|
Zhang J, Liu K, Peng P, Li S, Ye Z, Su Y,
Liu S, Qin M and Huang J: Upregulation of nectin-4 is associated
with ITGB1 and vasculogenic mimicry and may serve as a predictor of
poor prognosis in colorectal cancer. Oncol Lett. 18:1163–1170.
2019.PubMed/NCBI
|
